GeoBio Energy, Inc.

CIK:0001157004|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended		104 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013
Income Statement [Abstract]
Sales			$ 5		$ 17
Cost of sales	9		29		83
Gross profit (loss)	(9)		(24)		(66)
Operating Expenses
Selling and marketing					193
Research and development					103
General and administrative	188	401	865	1,282	27,166
Depreciation and amortization					185
Impairment					1,585
Total operating expenses	188	401	865	1,282	29,232
Loss from operations	(197)	(401)	(889)	(1,282)	(29,298)
Interest expense	(275)	(59)	(559)	(203)	(2,504)
Net gain on extinguishment of liabilities		99	3	99	272
Net loss	$ (472)	$ (361)	$ (1,445)	$ (1,386)	$ (31,530)
Net loss per common share - basic and diluted	$ (0.01)	$ (0.01)	$ (0.02)	$ (0.06)
Shares used in computing net loss per share - basic and diluted	79,258,912	33,116,962	75,108,717	22,570,695

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended		104 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013
Cash Flows From Operating Activities
Net loss	$ (1,445)	$ (1,386)	$ (31,530)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	26		219
Amortization of debt discount	237	17	1,422
Non-cash stock-based compensation for consulting, director fees and other expenses	44	41	18,140
Issuance of note payable as consideration for executive search services and expenses		11	336
Non-cash expense for bad debt reserve and write-down of inventory			59
Loss of assets due to fire			50
Non-cash extension or forebearance fee on note or advances payable			152
Impairment of assets			1,585
Net gain on extinguishment of liabilities	(3)	(99)	(272)
Changes in operating assets and liabilities, excluding assets and liabilities from acquisitions and dispositions:
Accounts receivable			(5)
Inventory			(79)
Prepaid expenses		6	6
Employee advances			(6)
Deposits			(6)
Accounts payable and accrued expenses and accrued payroll	1,064	1,211	7,139
Net cash used in operating activities	(77)	(199)	(2,790)
Cash Flows From Investing Activities
Purchases of property and equipment			(477)
Net cash used in investing activities			(477)
Cash Flows From Financing Activities
Advances for company expenses		17	559
Repayment of advances			(67)
Stockholder contributions and payment of expenses on behalf of the Company			493
Borrowings on notes payable	73	190	976
Proceeds from sale of units in private placement			755
Borrowings on related party notes			551
Net cash provided by financing activities	73	207	3,267
Net Change In Cash	(4)	8
Cash, beginning of period	4	5
Cash, end of period		13
Supplemental Disclosure:
Cash paid for interest
Cash paid for income taxes
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Issuance of common stock for Exclusive Distribution Agreement		75	75
Issuance of note payable for Exclusive Distribution Agreement		100	100
Conversion of advances payable to note payable		148	148
Conversion of advances payable to related party to accounts payable			23
Common and preferred shares issued on conversion or settlement of liabilities	48	147	1,771
Conversion of accounts payable to notes payable	595	232	2,630
Debt discount related to warrants issued with debt or beneficial conversion feature of convertible liabilities	175	52	1,382
Contribution of airplane and other assets by related party			139
Conversion of contributions of cash and airplane by related party to common stock			291
Accrued financing fees for private placement			(76)
Issuance of warrants as financing fee on private placement			(66)
Contribution of inventory and assets in exchange for units			47
Non-cash adjustment of assets and liabilities due to disposition:
Disposition of inventory			36
Disposition of advances			6
Disposition of deposits			6
Disposition of property and equipment			409
Settlement of payroll obligations			(261)
Settlement of related party payable and interest payable			(80)
Issuance of common stock for note and advances payable extension or forebearance fee			$ (152)

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Sep. 30, 2012
ASSETS
Cash		$ 4
Total current assets		4
Exclusive distribution agreement	149	175
Total assets	149	179
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Accounts payable and accrued expenses	1,485	1,639
Accrued payroll	2,039	1,443
Convertible and non-convertible notes payable to non-related parties, net of discount of $11 and $8, respectively	286	214
Convertible notes payable to related parties, net of discount of $3 and $54, respectively	1,831	945
Notes payable to related parties, net of discount of $6 and $33, respectively	822	1,077
Advances	148	145
Total current liabilities	6,611	5,463
Stockholders' Equity (Deficit)
Preferred stock and additional paid-in capital, $0.001 par value: 100,000,000 shares authorized; 30,000,000 shares designated as Series A at both June 30, 2013 and September 30, 2012; 17,775,000 issued and outstanding at both June 30, 2013 and September 30, 2012	71	71
Common stock and additional paid-in capital, $0.001 par value:1,000,000,000 shares authorized; 82,757,813 and 54,928,235 issued and outstanding at June 30, 2013 and September 30, 2012, respectively	24,997	24,730
Deficit accumulated during the development stage	(31,530)	(30,085)
Total stockholders' equity (deficit)	(6,462)	(5,284)
Total liabilities and stockholders' equity (deficit)	$ 149	$ 179